OS Therapies - Bathi operasional EBITDA OSTX
OS Therapies Incorporated (OSTX) focuses on treating rare pediatric bone tumors by developing anti-metastatic vaccines. Operating profit in cash equivalents on the general GURU.Markets platform chart shows that the current parameter is 0.00. This is supported by scientific alliances with oncology centers to develop immunotherapy, while operational processes are optimized by outsourcing trials to contract research organizations (CRO).
Ringkesan rincian data analitis OS Therapies (OSTX)
- kuotasi saiki lan rata-rata prakiraan nilai:
- rincian nilai pasar emiten:
- indikator nilai buku ekuitas:
- data tingkat utang lan likuiditas finansial:
Utang marang Modal OS Therapies Incorporated|OSTX - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal OS Therapies Inc.|OSTX - Gunggung utang perusahaan|Rasio utang marang aset resik OS Therapies|OSTX - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka cendhak OS Therapies|Rasio jangkoan perantara ostherapies.com
- statistik bathi lan rasio pasar:
OSTX - Bathi resik|Bathi resik sing dikarepake OS Therapies Incorporated|OSTX - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi ostherapies.com|OSTX - Pangali PEG|Pangali EV/EBITDA OS Therapies|OSTX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben siji saham sajrone 12 wulan pungkasan OS Therapies|OSTX - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan ostherapies.com|OSTX - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep OS Therapies Incorporated
Pambiji fundamental perusahaan:OS Therapies, Inc.
For OS Therapies Incorporated, which operates within a specific immuno-oncology drug development cycle, this metric serves as an indicator of operational efficiency excluding financial and tax expenses. By analyzing the EBITDA growth trajectory, an investor sees the current value of 0.00, which allows for an assessment of the business's intrinsic value based solely on clinical trial progress rather than external macroeconomic factors.
Analisis pesaing OS Therapies Incorporated
ONC - Bathi operasional sadurunge ngurangi amortisasi|HALO: Bathi operasional sadurunge ngurangi amortisasi|RVMD - Bathi operasional EBITDA|Ascentage Pharma (AAPG) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CG Oncology Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|URGN (UroGen) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Bicara Corp BCAX|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Personalis, Inc. (PSNL)|ERAS - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Delcath Systems DCTH|Pendapatan operasional sadurunge ngurangi amortisasi Y-mAbs Therapeutics Inc (YMAB)|AURA: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi CADL (Candel Therapeutics)|ARAY (Accuray Incorporated) - Bathi operasional sadurunge ngurangi amortisasi|SLS: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|ACTU (Actuate Therapeutics) - Bathi operasional EBITDA|CTOR: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA HURA|TARA - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Fate Therapeutics, Inc. FATE|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi WHWK|TScan - Bathi operasional EBITDA|CSBR - Bathi operasional EBITDA|xbiotech.com (XBIT) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi CVM (CEL-SCI)|RADX (Radiopharm Theranostics) - Bathi operasional EBITDA|Artiva (ARTV) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA ANL|VERU - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Tempest Tx TPST|Pendapatan operasional sadurunge ngurangi amortisasi Xilio Therapeutics Inc (XLO)|RENB: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi MURA (Mural Oncology plc)|KAPA: Bathi operasional EBITDA|OKUR - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi CytoMed Therapeutics Ltd|Bathi operasional sadurunge amortisasi CRIS (Curis Corp)|Bathi operasional EBITDA APLM|Bathi operasional sadurunge ngurangi amortisasi tharimmune.com THAR|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Advanced Biomed ADVB|Genprex Inc. (GNPX) - Bathi sadurunge bunga, pajak, lan amortisasi|CLDI - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi SBFM (sunshinebiopharma.com)|xeneticbio.com (XBIO) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi SLRX (salariuspharma.com)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Purple Biotech Ltd.|Bathi sadurunge bunga, pajak, lan amortisasi AON AONC|Bathi sadurunge mbayar bunga, pajak, lan amortisasi BeOne Medicines (BGNE)|CKPT (Checkpoint Therapeutics Inc) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA ELEV (Elevation Oncology)|Bathi operasional EBITDA iCAD Inc. ICAD|IKNA: Bathi operasional sadurunge ngurangi amortisasi|Notable Labs Ltd - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|VIRX: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi MorphoSys Corporation (MOR)|NAYA (NAYA Biosciences) - Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi AAPGV (ascentage.com)
